Stay updated on Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial page.

Latest updates to the Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedMajor update: adds a government funding and operating status notice and marks the page as revision v3.2.0, replacing v3.1.0.SummaryDifference2%

- Check28 days agoChange DetectedAdded a new revision label v3.1.0 and removed several drug-safety and pharmaceutical topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision v3.0.2. The update shifts the page toward a release/versioning focus while narrowing drug-related content.SummaryDifference0.3%

- Check43 days agoChange DetectedRevision updated to v3.0.2, and the 'Back to Top' link was removed.SummaryDifference0.1%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%

- Check57 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as specific resources related to Amyotrophic Lateral Sclerosis, while removing outdated location details and some related topics.SummaryDifference2%

- Check71 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12, indicating a revision in the content.SummaryDifference0.1%

Stay in the know with updates to Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial page.